IL17A and lobular neoplasia: Increased levels of IL-17 and sTWEAK were observed in SLE patients compared to HC, and in LN compared to non-LN groups. There was a significant positive association between serum IL-17 and TWEAK levels and SLEDAI, proteinuria, nephritis activity index, and other clinical manifestations (P < 0.05).